Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2021-08, Vol.35 (8), p.2403-2406
Hauptverfasser:	Goemans, Bianca F., Noort, Sanne, Blink, Marjolein, Wang, Yong-Dong, Peters, Susan T. C. J., van Wouwe, Jacobus P., Kaspers, Gertjan, de Haas, Valerie, Kollen, Wouter J., van der Velden, Vincent H. J., Gruber, Tanja A., Zwaan, Christian M.
Format:	Artikel
Sprache:	eng
Schlagworte:	13/31 14/63 38/47 45/22 45/77 631/208/2489/68 631/67/395 692/699/1541/1990/283/1897 Biomarkers, Tumor - genetics Cancer Research Complications and side effects Critical Care Medicine DNA Mutational Analysis Down syndrome Down Syndrome - complications Down's syndrome Early Detection of Cancer - methods Female Follow-Up Studies GATA-1 protein GATA1 Transcription Factor - genetics Gene mutations Genetic aspects Health aspects Hematology Humans Infant, Newborn Intensive Internal Medicine Letter Leukemia Leukemia, Myeloid - diagnosis Leukemia, Myeloid - etiology Leukemia, Myeloid - pathology Male Medicine Medicine & Public Health Mutation Myelocytic leukemia Myeloid leukemia Neonates Nonlymphoid leukemia Oncology Prenatal diagnosis Prognosis Retrospective Studies Risk factors Transcription factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!